Johnson Matthey (OTCMKTS:JMPLY) has received an average recommendation of “Hold” from the six research firms that are presently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company.
A number of equities analysts recently weighed in on JMPLY shares. Investec downgraded shares of Johnson Matthey from a “hold” rating to a “sell” rating in a report on Friday, April 12th. Zacks Investment Research upgraded shares of Johnson Matthey from a “hold” rating to a “buy” rating and set a $94.00 target price on the stock in a report on Wednesday, April 3rd.
Shares of JMPLY opened at $82.80 on Wednesday. Johnson Matthey has a 1-year low of $67.00 and a 1-year high of $99.65. The stock’s fifty day moving average price is $81.78.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Article: Does a trade war provide a risk to the global economy?
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.